Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical timolol for recurrent epistaxis
IRCT20240327061371N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of timolol in epistaxis, sponsored by Isfahan University of Medical Sciences. Started Oct 2024; status: completed.
02
Drugs
timolol
03
Conditions
epistaxis
Beyond the preview
Go deeper on IRCT20240327061371N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240327061371N1.